Lee Hye Ran, Lim Chiyeon, Yun Hyong Geun, Kang Seung Hee, Kim Do Yeun
Department of Internal Medicine, Inje University Ilsan Paik Hospital, Inje University College of Medicine, Goyang, South Korea.
Biostatistics of School of Medicine, Dongguk University, Seoul, South Korea.
Support Care Cancer. 2018 Jan;26(1):297-303. doi: 10.1007/s00520-017-3848-8. Epub 2017 Aug 8.
To give informed consent, a patient needs to sufficiently understand the information provided by a physician to decide among treatment options. Although shared decision-making is becoming an important aspect of patient-centered care, little is known about decision-making by cancer patients in Korea.
This study assessed Korean cancer patients' understanding of treatment goals and the need to obtain further information after a physician obtained informed consent for radiotherapy.
In this prospective study, doctors and patients completed questionnaires independently after informed consent for radiotherapy had been obtained. The questionnaires for the doctors and patients were comprised of matched items regarding treatment aims and the need for further information.
The study enrolled 103 cancer patients scheduled for radiotherapy. The proportion of respondents who stated that the intent of treatment was to bring about a cure was 80.6% among the patients (83 of 103 patients) and 53.4% (55 of 103 patients) among the doctors (p = 0.000). The proportion of respondents who believed that the aim was prolongation of life was 16.5 and 1.9%, respectively (p = 0.000). Regarding the need for further information, 42.7% (44/103) of the patients did not want further information because they had faith in the physicians' medical expertise.
Many Korean cancer patients misunderstand the aims of treatment and half of participants do not want further information. Physicians should address whether specific interventions can solve these barriers so that Korean cancer patients can make truly autonomous treatment decisions.
为了给予知情同意,患者需要充分理解医生提供的信息,以便在治疗方案中做出决定。尽管共同决策正成为以患者为中心的医疗的一个重要方面,但对于韩国癌症患者的决策情况却知之甚少。
本研究评估了韩国癌症患者对治疗目标的理解,以及在医生获得放射治疗知情同意后获取更多信息的需求。
在这项前瞻性研究中,医生和患者在获得放射治疗知情同意后独立完成问卷。医生和患者的问卷包括关于治疗目的和获取更多信息需求的匹配项目。
该研究纳入了103名计划接受放射治疗的癌症患者。患者中表示治疗目的是治愈的受访者比例为80.6%(103名患者中的83名),医生中这一比例为53.4%(103名患者中的55名)(p = 0.000)。认为治疗目的是延长生命的受访者比例分别为16.5%和1.9%(p = 0.000)。关于获取更多信息的需求,42.7%(44/103)的患者不希望获取更多信息,因为他们信任医生的专业医术。
许多韩国癌症患者误解了治疗目的,且一半的参与者不希望获取更多信息。医生应探讨是否有特定干预措施可以消除这些障碍,以便韩国癌症患者能够做出真正自主的治疗决策。